A detailed history of Creative One Wealth, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Creative One Wealth, LLC holds 18,089 shares of HALO stock, worth $859,951. This represents 0.04% of its overall portfolio holdings.

Number of Shares
18,089
Holding current value
$859,951
% of portfolio
0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$51.3 - $64.42 $927,965 - $1.17 Million
18,089 New
18,089 $1.03 Million
Q4 2022

Feb 14, 2023

BUY
$40.06 - $59.44 $190,044 - $281,983
4,744 New
4,744 $270,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Creative One Wealth, LLC Portfolio

Follow Creative One Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative One Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Creative One Wealth, LLC with notifications on news.